| Stress, depression, and neuroplasticity: a convergence of mechanisms C Pittenger, RS Duman Neuropsychopharmacology 33 (1), 88-109, 2008 | 2119 | 2008 |
| Analysis of shared heritability in common disorders of the brain Brainstorm Consortium, V Anttila, B Bulik-Sullivan, HK Finucane, ... Science 360 (6395), eaap8757, 2018 | 1229 | 2018 |
| Genomic relationships, novel loci, and pleiotropic mechanisms across eight psychiatric disorders PH Lee, V Anttila, H Won, YCA Feng, J Rosenthal, Z Zhu, EM Tucker-Drob, ... Cell 179 (7), 1469-1482. e11, 2019 | 915 | 2019 |
| Meta-analysis of the symptom structure of obsessive-compulsive disorder MH Bloch, A Landeros-Weisenberger, MC Rosario, C Pittenger, ... American Journal of Psychiatry 165 (12), 1532-1542, 2008 | 790 | 2008 |
| Reversible inhibition of CREB/ATF transcription factors in region CA1 of the dorsal hippocampus disrupts hippocampus-dependent spatial memory C Pittenger, YY Huang, RF Paletzki, R Bourtchouladze, H Scanlin, ... Neuron 34 (3), 447-462, 2002 | 554 | 2002 |
| Blocking TGF-β–Smad2/3 innate immune signaling mitigates Alzheimer-like pathology T Town, Y Laouar, C Pittenger, T Mori, CA Szekely, J Tan, RS Duman, ... Nature medicine 14 (6), 681-687, 2008 | 470 | 2008 |
| Some forms of cAMP-mediated long-lasting potentiation are associated with release of BDNF and nuclear translocation of phospho-MAP kinase SL Patterson, C Pittenger, A Morozov, KC Martin, H Scanlin, C Drake, ... Neuron 32 (1), 123-140, 2001 | 417 | 2001 |
| Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment C Pittenger, MH Bloch, K Williams Pharmacology & therapeutics 132 (3), 314-332, 2011 | 389 | 2011 |
| Toward a neurobiology of psychotherapy: basic science and clinical applications A Etkin, C Pittenger, HJ Polan, ER Kandel The Journal of Neuropsychiatry and Clinical Neurosciences 17 (2), 145-158, 2005 | 389 | 2005 |
| Riluzole augmentation in treatment-resistant obsessive–compulsive disorder: an open-label trial V Coric, S Taskiran, C Pittenger, S Wasylink, DH Mathalon, G Valentine, ... Biological psychiatry 58 (5), 424-428, 2005 | 370 | 2005 |
| Genome-wide association study of obsessive-compulsive disorder SE Stewart, D Yu, JM Scharf, BM Neale, JA Fagerness, CA Mathews, ... Molecular psychiatry 18 (7), 788-798, 2013 | 366 | 2013 |
| Altered global brain signal in schizophrenia GJ Yang, JD Murray, G Repovs, MW Cole, A Savic, MF Glasser, ... Proceedings of the National Academy of Sciences 111 (20), 7438-7443, 2014 | 347 | 2014 |
| Systematic review: pharmacological and behavioral treatment for trichotillomania MH Bloch, A Landeros-Weisenberger, P Dombrowski, B Kelmendi, ... Biological psychiatry 62 (8), 839-846, 2007 | 337 | 2007 |
| Characterization of a mutant strain of Saccharomyces cerevisiae with a deletion of the RAD27 gene, a structural homolog of the RAD2 nucleotide excision repair gene MS Reagan, C Pittenger, W Siede, EC Friedberg Journal of bacteriology 177 (2), 364-371, 1995 | 312 | 1995 |
| Distinct subcortical volume alterations in pediatric and adult OCD: a worldwide meta-and mega-analysis PSW Boedhoe, L Schmaal, Y Abe, SH Ameis, PD Arnold, MC Batistuzzo, ... American Journal of Psychiatry 174 (1), 60-69, 2017 | 309 | 2017 |
| Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder MH Bloch, J McGuire, A Landeros-Weisenberger, JF Leckman, ... Molecular psychiatry 15 (8), 850-855, 2010 | 305 | 2010 |
| Microglial dysregulation in psychiatric disease LR Frick, K Williams, C Pittenger Journal of Immunology Research 2013, 2013 | 301 | 2013 |
| Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture LK Davis, D Yu, CL Keenan, ER Gamazon, AI Konkashbaev, EM Derks, ... PLoS genetics 9 (10), e1003864, 2013 | 300 | 2013 |
| The NMDA receptor as a therapeutic target in major depressive disorder C Pittenger, G Sanacora, JH Krystal CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2007 | 278 | 2007 |
| N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder DL Lafleur, C Pittenger, B Kelmendi, T Gardner, S Wasylink, RT Malison, ... Psychopharmacology 184, 254-256, 2006 | 269 | 2006 |
Michael BlochYale Child Study CenterVerified email at yale.edu
